{"title":"胃癌根治性切除患者第二原发癌的危险因素","authors":"Kiyoshi Wakao, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Junichi Takamizawa, Mayuko Ueda, Norihiro Yuasa","doi":"10.1007/s10147-025-02848-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Despite improving long-term outcomes after gastrectomy for gastric cancer (GC), screening methods for second primary cancer (SPC) following resection remain challenging. This study aimed to investigate the cumulative incidence and risk factors for SPC in patients with curative resection for GC.</p><p><strong>Methods: </strong>We included 1128 patients who underwent R0 resection for Stage I/II/III GC. Incidence of duplicate cancers before and after gastrectomy was investigated. The cumulative incidence of SPC following gastrectomy was calculated, and the relationship between SPC occurrence and clinicopathological factors was analyzed.</p><p><strong>Results: </strong>During a median postoperative follow-up of 64 months, the most common SPCs were lung, prostate, and colorectal cancers. Additionally, lung and pancreatic cancers occurred significantly more frequently after gastrectomy than before. The cumulative incidence of SPCs was 7% at 5 years, 18% at 10 years, and 29% at 15 years. Multivariate analysis identified male sex, postoperative carcinoembryonic antigen (CEA) levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL at one month after gastrectomy as significant factors associated with SPC development.</p><p><strong>Conclusion: </strong>After gastrectomy for gastric cancer (GC), enhanced surveillance for SPCs can be tailored based on three factors: male sex, postoperative CEA levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL.</p>","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":"2012-2021"},"PeriodicalIF":2.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk factors for second primary cancers in patients with curatively resected gastric cancer.\",\"authors\":\"Kiyoshi Wakao, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Junichi Takamizawa, Mayuko Ueda, Norihiro Yuasa\",\"doi\":\"10.1007/s10147-025-02848-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Despite improving long-term outcomes after gastrectomy for gastric cancer (GC), screening methods for second primary cancer (SPC) following resection remain challenging. This study aimed to investigate the cumulative incidence and risk factors for SPC in patients with curative resection for GC.</p><p><strong>Methods: </strong>We included 1128 patients who underwent R0 resection for Stage I/II/III GC. Incidence of duplicate cancers before and after gastrectomy was investigated. The cumulative incidence of SPC following gastrectomy was calculated, and the relationship between SPC occurrence and clinicopathological factors was analyzed.</p><p><strong>Results: </strong>During a median postoperative follow-up of 64 months, the most common SPCs were lung, prostate, and colorectal cancers. Additionally, lung and pancreatic cancers occurred significantly more frequently after gastrectomy than before. The cumulative incidence of SPCs was 7% at 5 years, 18% at 10 years, and 29% at 15 years. Multivariate analysis identified male sex, postoperative carcinoembryonic antigen (CEA) levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL at one month after gastrectomy as significant factors associated with SPC development.</p><p><strong>Conclusion: </strong>After gastrectomy for gastric cancer (GC), enhanced surveillance for SPCs can be tailored based on three factors: male sex, postoperative CEA levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL.</p>\",\"PeriodicalId\":13869,\"journal\":{\"name\":\"International Journal of Clinical Oncology\",\"volume\":\" \",\"pages\":\"2012-2021\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10147-025-02848-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-025-02848-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
Risk factors for second primary cancers in patients with curatively resected gastric cancer.
Purpose: Despite improving long-term outcomes after gastrectomy for gastric cancer (GC), screening methods for second primary cancer (SPC) following resection remain challenging. This study aimed to investigate the cumulative incidence and risk factors for SPC in patients with curative resection for GC.
Methods: We included 1128 patients who underwent R0 resection for Stage I/II/III GC. Incidence of duplicate cancers before and after gastrectomy was investigated. The cumulative incidence of SPC following gastrectomy was calculated, and the relationship between SPC occurrence and clinicopathological factors was analyzed.
Results: During a median postoperative follow-up of 64 months, the most common SPCs were lung, prostate, and colorectal cancers. Additionally, lung and pancreatic cancers occurred significantly more frequently after gastrectomy than before. The cumulative incidence of SPCs was 7% at 5 years, 18% at 10 years, and 29% at 15 years. Multivariate analysis identified male sex, postoperative carcinoembryonic antigen (CEA) levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL at one month after gastrectomy as significant factors associated with SPC development.
Conclusion: After gastrectomy for gastric cancer (GC), enhanced surveillance for SPCs can be tailored based on three factors: male sex, postoperative CEA levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL.
期刊介绍:
The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.